Drug results: 1
| tirabrutinib hydrochloride | Tirabrutinib is a potent and selective Bruton’s tyrosine kinase (BTK) inhibitor that irreversibly and covalently binds to BTK Cys-481 in B cells and inhibits aberrant B cell receptor signalling in B cell-related cancers and autoimmune diseases. |
|








Citing DrugCentral © 2025.
License